Drug intelligence / Profile preview

ringer lactate + norepinephrine

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ringer Lactate + norepinephrine is a combination of two medical products used in clinical settings, particularly for patients with hypotension or in shock states. This combination consists of Ringer's lactate solution (an intravenous fluid) and norepinephrine (a vasopressor medication). ## Description Ringer Lactate (also known as Lactated Ringer's, RL, or Hartmann's solution) is an isotonic crystalloid fluid used for fluid resuscitation and electrolyte replacement. It contains sodium chloride, sodium lactate, potassium chloride, and calcium chloride in water[6]. The solution is isotonic with blood and has a pH of about 6.5[8]. Norepinephrine (also known as Levophed) is a sympathomimetic vasopressor that stimulates alpha-adrenergic receptors to produce vasoconstriction and increase blood pressure. At lower doses (<2 mcg/min), it also stimulates beta-adrenergic receptors to enhance myocardial contractility[4][5]. It is the first-line pharmacological agent for treating hypotension, particularly in vasodilatory shock states such as septic shock and neurogenic shock[5]. The combination is used in critical care settings where both fluid resuscitation and vasopressor support are needed simultaneously. ## Administration Norepinephrine can be administered as an IV infusion in Ringer's Lactate solution. The typical preparation is 8 mg of norepinephrine in 250 mL of Ringer's Lactate (32 mcg/mL)[4]. This combination allows for both fluid replacement and blood pressure support in critically ill patients. ## Compatibility According to compatibility studies, norepinephrine is physically compatible with Ringer's Lactate solution for intravenous administration[4][7]. This compatibility allows for the simultaneous delivery of both components through the same intravenous line, which can be particularly useful in emergency and critical care settings. ## Clinical Considerations When administering this combination: - Hypovolemia, hypoxemia, and acidosis should be corrected concurrently with initiation of therapy[4] - The norepinephrine component should be weaned off gradually - Close monitoring of blood pressure is essential - The solution may change color from clear to brown, indicating a loss of potency of the norepinephrine component[4] ## Precautions - Inadvertent boluses of norepinephrine may cause profound hypertension, potentially resulting in myocardial infarction or cerebral ischemia/bleeding[4] - Norepinephrine alone without inotropic therapy may worsen stroke volume in patients with left ventricular dysfunction and poor ejection fraction[4] - Potential adverse effects include bradycardia, cardiac arrhythmias, chest pain, renal ischemia, mesenteric ischemia, and hyperglycemia[4] - Norepinephrine is a vesicant which can cause progressive and severe tissue damage if extravasation occurs[4]

Other names
Lactated Ringer's + norepinephrineRL + norepinephrineHartmann's solution + norepinephrineSodium lactate solution + norepinephrineRinger's lactate + Levophed
02

Targets

ADRB2 (β2)ADRA2A (α2A)ADRA1A (α1A)ADRB3 (β3)ADRB1 (β1)

Beyond the preview

Go deeper on ringer lactate + norepinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ringer lactate + norepinephrine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call